Cargando…

Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure

Treatment of decompensated heart failure often includes administration of levosimendan. Myeloperoxidase (MPO) is released during polymorphonuclear neutrophil (PMN) degranulation, and mediates dysregulation of vascular tone in heart failure. We evaluated the effects of levosimendan-treatment on MPO i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adam, Matti, Meyer, Sven, Knors, Henning, Klinke, Anna, Radunski, Ulf K., Rudolph, Tanja K., Rudolph, Volker, Spin, Joshua M., Tsao, Philip S., Costard-Jäckle, Angelika, Baldus, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394753/ https://www.ncbi.nlm.nih.gov/pubmed/25867530 http://dx.doi.org/10.1038/srep09704

Ejemplares similares

Fibrosis in Atrial Fibrillation – Role of Reactive Species and MPO
por: Friedrichs, Kai, et al.
Publicado: (2012)

The Enzymatic and Non-Enzymatic Function of Myeloperoxidase (MPO) in Inflammatory Communication
por: Kargapolova, Yulia, et al.
Publicado: (2021)

Non-invasive assessment of central venous pressure in heart failure: a systematic prospective comparison of echocardiography and Swan-Ganz catheter
por: Szymczyk, Tobias, et al.
Publicado: (2020)

Assessment of changes in cardiac volumes following MitraClip™ implantation using cardiac magnetic resonance imaging
por: Radunski, Ulf K, et al.
Publicado: (2012)

Induction of Atrial Fibrillation by Neutrophils Critically Depends on CD11b/CD18 Integrins
por: Friedrichs, Kai, et al.
Publicado: (2014)

Addition of levosimendan to overcome acute cardiogenic shock—Paving the way for later heart transplantation—A first case report
por: Flottmann, Christian, et al.
Publicado: (2020)

Catheter ablation for atrial fibrillation in patients with end‐stage heart failure and eligibility for heart transplantation
por: Sohns, Christian, et al.
Publicado: (2020)

MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits
por: Matsumoto, Kei, et al.
Publicado: (2009)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

The role of myeloperoxidase and myeloperoxidase–antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis
por: Arimura, Yoshihiro, et al.
Publicado: (2013)

Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
por: Kundra, Tanveer Singh, et al.
Publicado: (2018)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Renal Effects of Levosimendan: A Consensus Report
por: Yilmaz, Mehmet B., et al.
Publicado: (2013)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Myeloperoxidase deficiency preserves vasomotor function in humans
por: Rudolph, Tanja K., et al.
Publicado: (2012)

Temporal Dissociation between Myeloperoxidase (MPO)-Modified LDL and MPO Elevations during Chronic Sleep Restriction and Recovery in Healthy Young Men
por: Zouaoui Boudjeltia, Karim, et al.
Publicado: (2011)

Focusing X-rays Using Micropore Optics (MPO)
por: Catenza, Jam Lambert Ubay
Publicado: (2022)

Membranous Nephropathy With MPO-ANCA-Associated Crescentic GN
por: Kanodia, Kamal, et al.
Publicado: (2014)

MPO-C-ANCA-associated necrotising and crescentic glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2017)

MPO-ANCA Rapidly Progressive Glomerulonephritis with Immune Deposits
por: Acosta, Eric, et al.
Publicado: (2022)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Levosimendan in Right Ventricular Dysfunction
por: Kapoor, Mukul C.
Publicado: (2023)

Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients
por: Schramm, René, et al.
Publicado: (2021)

Severe chronic non-bacterial osteomyelitis associated with MPO deficiency
por: Berg, Stefan, et al.
Publicado: (2014)

Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response
por: Costard-Jäckle, Angelika, et al.
Publicado: (2022)

Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement
por: Mauri, Victor, et al.
Publicado: (2020)

Myocardial efficiency during levosimendan infusion
por: Voipio-Pulkki, L-M, et al.
Publicado: (2002)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Levosimendan for Perioperative Cardioprotection: Myth or Reality?
por: Santillo, Elpidio, et al.
Publicado: (2018)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Role of inhaled levosimendan in peripartum cardiomyopathy
por: Kaur, Parminder, et al.
Publicado: (2022)

Mitochondrial Integrity Is Critical in Right Heart Failure Development
por: Müller, Marion, et al.
Publicado: (2023)

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
por: Herpain, Antoine, et al.
Publicado: (2019)

Levosimendan: current data, clinical use and future development
por: Nieminen, M S, et al.
Publicado: (2013)

Involvement of Myeloid Cells and Noncoding RNA in Abdominal Aortic Aneurysm Disease
por: Knappich, Christoph, et al.
Publicado: (2020)

Temporal trends of TAVI treatment characteristics in high volume centers in Germany 2013–2020
por: Mauri, Victor, et al.
Publicado: (2021)

A Stepwise Approach for Transcatheter Edge-to-Edge Repair in Very Advanced Tricuspid Regurgitation
por: Ivannikova, Maria, et al.
Publicado: (2023)

Valve-in-Valve TAVR versus Redo Surgical Aortic Valve Replacement: Early Outcomes
por: Cizmic, Amila, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ueu3ck2vtrmp3mt1mls2irbibh